Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galangin Reverses Hepatic Fibrosis by Inducing HSCs Apoptosis <i>via</i> the PI3K/Akt, Bax/Bcl-2, and Wnt/β-Catenin Pathway in LX-2 Cells
Yuanguo Xiong, Hao Lü, Hanlin Xu
Biological and Pharmaceutical Bulletin (2020) Vol. 43, Iss. 11, pp. 1634-1642
Open Access | Times Cited: 23

Showing 23 citing articles:

Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions
Megh Pravin Vithalkar, Shaili Pradhan, K. Sandra, et al.
Cell Biochemistry and Biophysics (2025)
Open Access | Times Cited: 1
Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update
Yu Zheng, Long Xie, Dejun Yang, et al.
Phytomedicine (2023) Vol. 113, pp. 154721-154721
Closed Access | Times Cited: 17
Pharmacological activities and therapeutic potential of galangin, a promising natural flavone, in age-related diseases
Fan Zhang, Yan Yu, Linmei Zhang, et al.
Phytomedicine (2023) Vol. 120, pp. 155061-155061
Closed Access | Times Cited: 12
Galangin delivered by retinoic acid-modified nanoparticles targeted hepatic stellate cells for the treatment of hepatic fibrosis
Yuanguo Xiong, Bing Wu, Xianxi Guo, et al.
RSC Advances (2023) Vol. 13, Iss. 16, pp. 10987-11001
Open Access | Times Cited: 11
Phytochemical and pharmacological properties of the genus Alpinia from 2016 to 2023
Isoo Youn, Ah‐Reum Han, Donglan Piao, et al.
Natural Product Reports (2024) Vol. 41, Iss. 9, pp. 1346-1367
Open Access | Times Cited: 4
Preventive and Therapeutic Effects of Baicalein, Galangin, and Isorhamnetin in Chronic Liver Diseases: A Narrative Review
Giuseppe Guido Maria Scarlata, Israel López, Maria Luisa Gambardella, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1253-1253
Open Access
Downregulation of S100 calcium-binding A4 (S100A4) ameliorates hepatic fibrosis <i>via</i> regulating Wnt/β-catenin signaling pathway
Chi‐Xian Zhang, Kai Bai, Dexu Li
European Journal of Histochemistry (2025) Vol. 69, Iss. 2
Open Access
FR429 from <i>Polygonum capitatum</i> Demonstrates Potential as an Anti-hepatic Injury Agent by Modulating PI3K/Akt Signaling Pathway
Yaru Yang, Lei He, Minghui He, et al.
Biological and Pharmaceutical Bulletin (2025) Vol. 48, Iss. 4, pp. 372-382
Open Access
Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways
Cheng Wang, Shenglin Zhang, Yanzhi Li, et al.
Inflammation (2024) Vol. 47, Iss. 4, pp. 1403-1422
Closed Access | Times Cited: 2
Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: Molecular Mechanisms and Nanoparticulate Drug Delivery Systems
Alina Ciceu, Ferenc Fenyvesi, Anca Hermenean, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9346-9346
Open Access | Times Cited: 2
Traditional Chinese medicine targets on hepatic stellate cells for the treatment of hepatic fibrosis: A mechanistic review
Dengcheng Hui, Lu Liu, Yanqin Bian, et al.
Portal hypertension & cirrhosis (2023) Vol. 2, Iss. 1, pp. 16-31
Open Access | Times Cited: 6
Galangin inhibits neointima formation induced by vascular injury via regulating the PI3K/AKT/mTOR pathway
Bing Wu, Changwu Xu, Hua‐Sheng Ding, et al.
Food & Function (2022) Vol. 13, Iss. 23, pp. 12077-12092
Closed Access | Times Cited: 9
Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis
Jin-Zhong Li, Ning Chen, Nan Ma, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7936-7936
Open Access | Times Cited: 5
The potential of flavonoids in hepatic fibrosis: A comprehensive review
Wenbo Zhu, Jianwei Han, Liu Hua, et al.
Phytomedicine (2024) Vol. 133, pp. 155932-155932
Closed Access | Times Cited: 1
Carthamus tinctorius L. inhibits hepatic fibrosis and hepatic stellate cell activation by targeting the PI3K/Akt/mTOR pathway
Zhiheng Dong, Haibin Guan, Lu Wang, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 1
Glaucocalyxin A attenuates carbon tetrachloride‐induced liver fibrosis and improves the associated gut microbiota imbalance
Ru Qu, Wang Zhang, Zhuang Ma, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 1, pp. 51-64
Closed Access | Times Cited: 3
Enhanced Type I Collagen Synthesis in Fibroblasts by Dermal Stem/Progenitor Cell-Derived Exosomes
Ayumi Sanada, Takaaki Yamada, Seiji Hasegawa, et al.
Biological and Pharmaceutical Bulletin (2022) Vol. 45, Iss. 7, pp. 872-880
Open Access | Times Cited: 5
Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway
Tianyun Wang, Wei-Hua Dong, Fang Wang, et al.
Recent Patents on Anti-Cancer Drug Discovery (2021) Vol. 17, Iss. 2, pp. 178-186
Closed Access | Times Cited: 7
Recent Advances in Research on Active Compounds Against Hepatic Fibrosis
Chuang Liu, Siqi Li, Changhao Zhang, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2571-2628
Closed Access | Times Cited: 2
CDK9 Inhibitor Induces Apoptosis, Autophagy, and Suppression of Tumor Growth in Adult T-Cell Leukemia/Lymphoma
Naho Kato, Tomohiro Kozako, Takeo Ohsugi, et al.
Biological and Pharmaceutical Bulletin (2023) Vol. 46, Iss. 9, pp. 1269-1276
Open Access | Times Cited: 2
Ca<sup>2+</sup> Signaling and Proliferation <i>via</i> Ca<sup>2+</sup>-Sensing Receptors in Human Hepatic Stellate LX-2 Cells
Rubii Kondo, Naoki Kawata, Yoshiaki Suzuki, et al.
Biological and Pharmaceutical Bulletin (2022) Vol. 45, Iss. 5, pp. 664-667
Open Access | Times Cited: 3
Research Progress of Chinese Medicine in the Regulation of Liver Fibrosis-Related Signaling Pathways
Shihao Zheng, Chengyuan Xue, Size Li, et al.
The American Journal of Chinese Medicine (2024), pp. 1-36
Closed Access
The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols
Chengu Niu, Jing Zhang, Patrick Okolo
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 944-961
Closed Access
Signaling pathways that activate hepatic stellate cells during liver fibrosis
Youtian Zhang, Long Ren, Yinting Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Utilizing a Combination of Network Pharmacology and Experimental Validation to Unravel the Mechanism by Which Kuanxiongzhuyu Decoction Ameliorates Myocardial Infarction Damage
Yihao Wu, Miaofu Li, Liuying Chen, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1740-1740
Open Access
Page 1

Scroll to top